Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor.

Gnacadja G, Shoshitaishvili A, Gresser MJ, Varnum B, Balaban D, Durst M, Vezina C, Li Y.

J Theor Biol. 2007 Feb 7;244(3):478-88. Epub 2006 Jul 26.

PMID:
17011587
2.

Atroposelective synthesis of axially chiral biaryl compounds.

Bringmann G, Price Mortimer AJ, Keller PA, Gresser MJ, Garner J, Breuning M.

Angew Chem Int Ed Engl. 2005 Aug 26;44(34):5384-427.

PMID:
16116589
3.

Catalytic inactivation of protein tyrosine phosphatase CD45 and protein tyrosine phosphatase 1B by polyaromatic quinones.

Wang Q, Dubé D, Friesen RW, LeRiche TG, Bateman KP, Trimble L, Sanghara J, Pollex R, Ramachandran C, Gresser MJ, Huang Z.

Biochemistry. 2004 Apr 13;43(14):4294-303.

PMID:
15065873
4.

Novel caged fluorescein diphosphates as photoactivatable substrates for protein tyrosine phosphatases.

Wang Q, Scheigetz J, Roy B, Ramachandran C, Gresser MJ.

Biochim Biophys Acta. 2002 Nov 19;1601(1):19-28.

PMID:
12429499
5.

In vitro PKA phosphorylation-mediated human PDE4A4 activation.

Laliberté F, Liu S, Gorseth E, Bobechko B, Bartlett A, Lario P, Gresser MJ, Huang Z.

FEBS Lett. 2002 Feb 13;512(1-3):205-8.

6.

Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.

Liu S, Laliberté F, Bobechko B, Bartlett A, Lario P, Gorseth E, Van Hamme J, Gresser MJ, Huang Z.

Biochemistry. 2001 Aug 28;40(34):10179-86.

PMID:
11513595
7.

Cyclooxygenase-2 inhibitors.

Nies AS, Gresser MJ.

Adv Protein Chem. 2001;56:115-41. Review. No abstract available.

PMID:
11329851
8.

Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

Riendeau D, Percival MD, Brideau C, Charleson S, Dubé D, Ethier D, Falgueyret JP, Friesen RW, Gordon R, Greig G, Guay J, Mancini J, Ouellet M, Wong E, Xu L, Boyce S, Visco D, Girard Y, Prasit P, Zamboni R, Rodger IW, Gresser M, Ford-Hutchinson AW, Young RN, Chan CC.

J Pharmacol Exp Ther. 2001 Feb;296(2):558-66.

PMID:
11160644
9.

A general method for the rapid characterization of tyrosine-phosphorylated proteins by mini two-dimensional gel electrophoresis.

Ducret A, Desponts C, Desmarais S, Gresser MJ, Ramachandran C.

Electrophoresis. 2000 Jun;21(11):2196-208.

PMID:
10892730
10.

Conformational difference between PDE4 apoenzyme and holoenzyme.

Laliberté F, Han Y, Govindarajan A, Giroux A, Liu S, Bobechko B, Lario P, Bartlett A, Gorseth E, Gresser M, Huang Z.

Biochemistry. 2000 May 30;39(21):6449-58.

PMID:
10828959
11.

Bis(N,N-dimethylhydroxamido)hydroxooxovanadate inhibition of protein tyrosine phosphatase activity in intact cells: comparison with vanadate.

Cuncic C, Desmarais S, Detich N, Tracey AS, Gresser MJ, Ramachandran C.

Biochem Pharmacol. 1999 Dec 15;58(12):1859-67.

PMID:
10591140
12.

Vanadate inhibition of protein tyrosine phosphatases in Jurkat cells: modulation by redox state.

Cuncic C, Detich N, Ethier D, Tracey AS, Gresser MJ, Ramachandran C.

J Biol Inorg Chem. 1999 Jun;4(3):354-9.

PMID:
10439081
13.

Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I, et al.

J Pharmacol Exp Ther. 1999 Aug;290(2):551-60.

PMID:
10411562
14.

The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor.

Prasit P, Wang Z, Brideau C, Chan CC, Charleson S, Cromlish W, Ethier D, Evans JF, Ford-Hutchinson AW, Gauthier JY, Gordon R, Guay J, Gresser M, Kargman S, Kennedy B, Leblanc Y, Léger S, Mancini J, O'Neill GP, Ouellet M, Percival MD, Perrier H, Riendeau D, Rodger I, Zamboni R, et al.

Bioorg Med Chem Lett. 1999 Jul 5;9(13):1773-8.

PMID:
10406640
15.

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.

Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP.

Science. 1999 Mar 5;283(5407):1544-8.

16.

A two-component affinity chromatography purification of Helix pomatia arylsulfatase by tyrosine vanadate.

Skorey KI, Johnson NA, Huyer G, Gresser MJ.

Protein Expr Purif. 1999 Mar;15(2):178-87.

PMID:
10049673
17.
18.

Kinetic mechanism of glutathione conjugation to leukotriene A4 by leukotriene C4 synthase.

Gupta N, Gresser MJ, Ford-Hutchinson AW.

Biochim Biophys Acta. 1998 Mar 30;1391(2):157-68.

PMID:
9554994
19.

Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases.

Huyer G, Kelly J, Moffat J, Zamboni R, Jia Z, Gresser MJ, Ramachandran C.

Anal Biochem. 1998 Apr 10;258(1):19-30.

PMID:
9527843
20.

How does alendronate inhibit protein-tyrosine phosphatases?

Skorey K, Ly HD, Kelly J, Hammond M, Ramachandran C, Huang Z, Gresser MJ, Wang Q.

J Biol Chem. 1997 Sep 5;272(36):22472-80.

21.

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.

Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC, et al.

Br J Pharmacol. 1997 May;121(1):105-17.

22.

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate.

Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C.

J Biol Chem. 1997 Jan 10;272(2):843-51.

23.

Purification of baculovirus-overexpressed cytosolic phospholipase A2 using a single-step affinity column chromatography.

Abdullah KM, Leger S, Perrier H, Cromlish WA, Kennedy B, Gresser M.

Protein Expr Purif. 1995 Jun;6(3):291-7.

PMID:
7663164
24.

Inhibition of soybean lipoxygenase-1 by a diaryl-N-hydroxyurea by reduction of the ferric enzyme.

Desmarais SR, Riendeau D, Gresser MJ.

Biochemistry. 1994 Nov 15;33(45):13391-400.

PMID:
7947748
25.

5-Lipoxygenase.

Ford-Hutchinson AW, Gresser M, Young RN.

Annu Rev Biochem. 1994;63:383-417. Review. No abstract available.

PMID:
7979243
26.
27.
28.

The distribution and half-life for retention of vanadium in the organs of normal and diabetic rats orally fed vanadium(IV) and vanadium(V).

Ramanadham S, Heyliger C, Gresser MJ, Tracey AS, McNeill JH.

Biol Trace Elem Res. 1991 Aug;30(2):119-24.

PMID:
1723884
29.

Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradation.

Rouzer CA, Riendeau D, Falgueyret JP, Lau CK, Gresser MJ.

Biochem Pharmacol. 1991 May 1;41(9):1365-73.

PMID:
2018568
30.

Inhibition of phosphoglucomutase by vanadate.

Percival MD, Doherty K, Gresser MJ.

Biochemistry. 1990 Mar 20;29(11):2764-9.

PMID:
2140696
31.

Interaction of ox heart mitochondrial F1-ATPase with immobilized ADP and ATP.

Beharry S, Gresser MJ, Bragg PD.

Biochem J. 1990 Mar 15;266(3):835-41.

32.

Inhibition of phosphatase and sulfatase by transition-state analogues.

Stankiewicz PJ, Gresser MJ.

Biochemistry. 1988 Jan 12;27(1):206-12.

PMID:
3280015
33.
34.

2,3-diphosphoglycerate phosphatase activity of phosphoglycerate mutase: stimulation by vanadate and phosphate.

Stankiewicz PJ, Gresser MJ, Tracey AS, Hass LF.

Biochemistry. 1987 Mar 10;26(5):1264-9.

PMID:
3032246
36.
37.

Evaluation of the 24-h API 20A anaerobe system for identification of Clostridium difficile.

Gresser ME, Shanholtzer CJ, Gerding DN, Garrett CR, Peterson LR.

J Clin Microbiol. 1984 Jun;19(6):915-6.

38.

Inhibition of mitochondrial F1-ATPase by adenylyl imidodiphosphate.

Gresser MJ, Beharry S, Moennich DM.

Curr Top Cell Regul. 1984;24:365-78. No abstract available.

PMID:
6238810
39.

Synthesis and hydrolysis of ADP-arsenate by beef heart submitochondrial particles.

Moore SA, Moennich DM, Gresser MJ.

J Biol Chem. 1983 May 25;258(10):6266-71.

40.
42.
43.

Assessment of total catalytic sites and the nature of bound nucleotide participation in photophosphorylation.

Rosen G, Gresser M, Vinkler C, Boyer PD.

J Biol Chem. 1979 Nov 10;254(21):10654-61. No abstract available.

44.
45.

Acetyl coenzyme A: arylamine acetyltransferase. Measurement of the steady state concentration of the acetyl-enzyme intermediate.

Jencks WP, Gresser M, Valenzuela MS, Huneeus FC.

J Biol Chem. 1972 Jun 25;247(12):3756-60. No abstract available.

Supplemental Content

Loading ...
Support Center